Samuel Johnson
TetraLogic Pharmaceuticals (United States)
ORCID: 0000-0001-6145-0521MedicineImmunology and Microbiology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 2 papers. Top paper: “Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer’s disease”.
N/A
13 citations
Juan Pablo Palavicini, Justin Melendez, Nicolas R. Barthélemy, Yingxin He, Tiffany F. Kautz +22 more
4 citations
Cameron W. Flowers, Mengting Liu, Matthew P. Agdanowski, Samuel Johnson, J. Summers +16 more